중동 및 아프리카 백신 보조제 시장 전망 2030년까지 – 지역 분석 – 보조제 종류(미네랄 소금 보조제, 에멀전 보조제, 리포솜 보조제 및 기타) 및 유형(인간 백신 보조제 및 수의학 백신 보조제)별
기술 발전으로 중동 및 아프리카 백신 보조제 시장이 강화됨
현재 알루미늄 염 또는 젤 기반 보조제는 주로 허가된 백신에 사용됩니다. 모노포스포릴 지질 A(MPL) 보조제와 소수성 공중합체는 이러한 구성 요소의 예입니다. 소수성 미세구는 백신 생산 중에 과제를 제기합니다. 이러한 문제에는 많은 환경 폐기물 처리 및 오염 문제가 포함되며 시간이 많이 걸리고 비용이 많이 들며 비효율적입니다. 따라서 제조업체는 유기 용매 사용을 피하기 위한 새로운 기술 개발을 강조하고 있습니다. 예를 들어, Aphios의 백신 보조제 기술은 나노기술을 포괄하며, 그 생산에는 에탄올과 같은 극성 공용매가 있거나 없는 초임계, 임계 또는 근임계 유체[초유체(SFS)라고 함]가 포함됩니다. 생분해성 바이오폴리머는 SFS에 용해되고 수용액이나 나노입자 슬러리로 단위 백신과 혼합됩니다. 따라서 이러한 새로운 백신 보조제 기술은 백신 제조업체가 유기 용매의 사용을 배제할 수 있도록 하는 새로운 공정을 통해 생분해성 폴리머 나노구(PNS)를 만드는 데 개발되고 있습니다. 따라서 기술적 발전은 향후 몇 년 동안 백신 보조제 시장에 새로운 트렌드를 가져올 가능성이 높습니다.
중동 및 아프리카 백신 보조제 시장 개요
중동 및 아프리카 백신 보조제 시장은 사우디 아라비아, 남아프리카, UAE 및 기타 중동 및 아프리카로 세분화되었습니다. 제품 승인 증가는 사우디아라비아 백신 보조제 시장의 긍정적 성장을 이끄는 주요 원동력입니다. SAFDA의 제품 승인은 보조제 백신의 채택을 강화하고 사우디아라비아에서 향후 몇 년 동안 채택을 가속화하여 2020년에서 2030년 사이 시장 성장을 촉진할 것입니다.
중동 및 아프리카 백신 보조제 시장 수익 및 2030년 예측(백만 달러)
중동 및 아프리카 백신 보조제 시장 세분화
중동 및 아프리카 백신 보조제 시장은 보조제 종류, 유형 및 국가로 분류됩니다.
중동 및 아프리카 백신 보조제 시장은 보조제 종류에 따라 미네랄 소금 보조제, 에멀전 보조제, 리포솜 보조제 등으로 세분화됩니다. 미네랄 소금 보조제 세그먼트는 2022년 중동 및 아프리카 백신 보조제 시장 점유율에서 가장 큰 점유율을 차지했습니다.
중동 및 아프리카 백신 보조제 시장은 유형별로 인간용 백신 보조제와 수의용 백신 보조제로 나뉩니다. 인간용 백신 보조제 세그먼트는 2022년 중동 및 아프리카 백신 보조제 시장에서 더 큰 점유율을 차지했습니다.
국가별로 중동 및 아프리카 백신 보조제 시장은 사우디아라비아, 남아프리카, UAE, 기타 중동 및 아프리카로 세분화됩니다. 사우디아라비아는 2022년 중동 및 아프리카 백신 보조제 시장 점유율을 지배했습니다.
Croda International Plc; CSL Ltd; GSK Plc; Novavax Inc; 및 Phibro Animal Health Corp는 중동 및 아프리카 백신 보조제 시장에서 운영되는 일부 선도 기업입니다.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics
4.1 Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic
4.2.2 Approvals of Veterinary Vaccine Adjuvants
4.3 Market Restraints
4.3.1 Product Recalls and Adverse Effects
4.4 Market Opportunities
4.4.1 Advancements in Biotechnology and Immunology
4.5 Future Trends
4.5.1 Technological Advancements
4.6 Impact of Drivers and Restraints:
5. Vaccine Adjuvants Market –Middle East & Africa Market Analysis
5.1 Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
5.2 Middle East & Africa Vaccine Adjuvants Market Forecast and Analysis
6. Middle East & Africa Vaccine Adjuvants Market Analysis –by Adjuvant Class
6.1 Overview
6.2 Mineral Salt Adjuvant
6.2.1 Overview
6.2.2 Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Emulsion Adjuvant
6.3.1 Overview
6.3.2 Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liposome Adjuvant
6.4.1 Overview
6.4.2 Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Vaccine Adjuvants Market Analysis – by Type
7.1 Human Vaccine Adjuvant
7.1.1 Overview
7.1.2 Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Veterinary Vaccine Adjuvant
7.2.1 Overview
7.2.2 Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Vaccine Adjuvants Market –Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.1.4 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 South Africa: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.2.4 South Africa: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.3 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.3.4 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.4 Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.4.4 Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Type
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Global Vaccine Adjuvants Market
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10. Company Profiles
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 CSL Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Croda International Plc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novavax Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Phibro Animal Health Corp
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
11. Appendix
11.1 About The Insight Partners
List of Tables
Table 1. Middle East & Africa Vaccine Adjuvants Market Segmentation
Table 2. Middle East & Africa Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)
Table 3. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 4. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 5. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 6. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 7. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 8. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 9. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 10. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
List of Figures
Figure 1. Middle East & Africa Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030
Figure 4. Middle East & Africa Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)
Figure 5. Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)
Figure 10. Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East and Africa Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)
Figure 13. Middle East and Africa Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 14. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 15. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 16. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 17. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Growth Strategies in the Vaccine Adjuvants Market
- Croda International Plc
- CSL Ltd
- GSK Plc
- Novavax Inc
- Phibro Animal Health Corp
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa vaccine adjuvants market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa vaccine adjuvants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa vaccine adjuvants market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.